Pediatric Bipolar Depression

PHASE3CompletedINTERVENTIONAL
Enrollment

193

Participants

Timeline

Start Date

January 31, 2009

Primary Completion Date

November 30, 2010

Study Completion Date

November 30, 2010

Conditions
Bipolar Depression
Interventions
DRUG

Quetiapine XR

Oral treatment with 150 up to 300 mg/day once daily in the evening

DRUG

Placebo

Oral treatment once daily in the evening

Trial Locations (48)

Unknown

Research Site, Dothan

Research Site, Scottsdale

Research Site, Little Rock

Research Site, Escondido

Research Site, Bradenton

Research Site, Gainsville

Research Site, North Miami

Research Site, Tampa

Research Site, Atlanta

Research Site, Smyrna

Research Site, Eagle

Research Site, Hoffman Estates

Research Site, Terre Haute

Research Site, Overland Park

Research Site, Wichita

Research Site, Clinton Township

Research Site, Minneapolis

Research Site, Flowood

Research Site, St Louis

Research Site, Lincoln

Research Site, Rochester

Research Site, Cincinnati

Research Site, Cleveland

Research Site, Mason

Research Site, Oklahoma City

Research Site, Charleston

Research Site, Memphis

Research Site, Wharton

Research Site, Virginia Beach

Research Site, Bothell

Research Site, Milwaukee

Research Site, Bogota D.c

Research Site, Bello

Research Site, Bogotá

Research Site, Medellín

Research Site, Vijaywada

Research Site, Ahmedabad

Research Site, Vadodara

Research Site, Varanasi

Research Site, León

Research Site, Monterrey

Research Site, Belgrade

Research Site, Novi Sad

Research Site, Pretoria

Research Site, Cape Town

Research Site, Taoyuan District

Research Site, Changhua

Research Site, Taipei

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY